Related Experiment Videos
[The Israeli pharmaceutical market]
1Pharmaceutical Policy and Economics Unit, Israeli Center for Health Technology Assessment in Health Care, Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer.
Harefuah
|August 26, 2000
Summary
Israel's pharmaceutical market evolved significantly, with new regulations impacting drug pricing and usage. The diversified market allows for lower drug procurement costs for health funds.
Area of Science:
- Pharmaceutical Market Analysis
- Health Economics
- Drug Utilization Studies
Context:
- The Israeli pharmaceutical market experienced substantial changes between 1992 and 1995.
- The implementation of the National Health Insurance Law in 1995 marked a significant regulatory shift.
- National health expenditure on pharmaceuticals was 9.4% in 1994.
Purpose:
- To detail regulatory measures affecting drug prices and utilization in Israel from 1992-1995.
- To provide an informational basis for pharmaceutical marketing, dispensing, and economic planning.
- To support clinical practice for physicians and pharmacists.
Summary:
- The study analyzes major changes in Israel's pharmaceutical sector, focusing on drug pricing and utilization pre- and post-National Health Insurance Law implementation.
- Israel's pharmaceutical market is characterized by diversification and development, evidenced by numerous registered drugs and clinical trials.
- The market's scale provides an advantage, enabling lower drug purchase prices for public sick funds compared to the private sector.
Impact:
- Provides essential data for pharmaceutical market stakeholders, including marketers, dispensers, and policymakers.
- Informs economic planning within the public health system regarding pharmaceutical expenditure.
- Offers insights for clinicians (physicians and pharmacists) on drug availability and pricing dynamics.